A New Class of Cancer Drug.
Kills Cancer Cells. Protects Normal Tissue.
Keeping America Safe
Protecting Civilians, First Responders and Our Military
from Nuclear Accidents and Terrorism.
Vice Admiral Matthew L. Nathan, M.D., Former Surgeon General of the U.S. Navy, Joins Humanetics Medical advisory board
Humanetics Presents Data for Cancer Drug
Humanetics Receives New Grant from NASA
Humanetics Receives $3.8 Million Grant from Department of Defense
Humanetics Receives Patent for Cancer Drug
Humanetics to Present at Department of Defense Scientific Meeting
Humanetics Awarded Patent to Mitigate Erectile Dysfunction Associated with Prostate Cancer Radiotherapy
Humanetics Receives $597,000 Federal Grant to Continue Development of BIO 300 as a Medical Radiation Countermeasure
National Space Biology Research Institute to Fund Testing of BIO 300 to Protect Astronauts from Space Radiation